DEODIAL GUIADEEN,DONALD SPERBECK,GANG ZHOU,GINGER XU-QIANG YANG,HEPING WU,JAMES M. BALKOVEC,JEFFREY T. KUETHE,JIAN LIU,KEVIN D. DYKSTRA,PAULINE C. TING,QINGMEI HONG,ROBERT ASLANIAN,ROBERT J. DE VITA,R
申请号:
BR112013030883
公开号:
BR112013030883A2
申请日:
2012.06.01
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
Described herein are compounds of formula (I), The compounds of formula I act as DGAT1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.